Karl-Norbert Klotz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 9

Top Topics

Capillary Electrophoresis

Molecular Dynamics

Breast Cancer Cells

Top Venues

Chemical biology & drug design

Journal of medicinal chemistry

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron Tan, Maria V Babak, Gopalakrishnan Venkatesan, Clarissa Lim, Karl-Norbert Klotz, Deron Raymond Herr, Siew Lee Cheong, Stephanie Federico, Giampiero Spalluto, Wei-Yi Ong, Yu Zong Chen, Jason Siau Ee Loo, Giorgia Pastorin
Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy. Molecules (Basel, Switzerland) 24 (20) (2019)
Maria João Matos, Santiago Vilar, Saleta Vazquez-Rodriguez, Sonja Kachler, Karl-Norbert Klotz, Michela Buccioni, Giovanna Lucia Delogu, Lourdes Santana, Eugenio Uriarte, Fernanda Borges
Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists. Journal of medicinal chemistry 63 (5) (2019)
Marthe Koussémou, Karl-Norbert Klotz
Agonists activate different A2B adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies. Naunyn-Schmiedeberg's archives of pharmacology 392 (12) (2019)
Khasim Shaik, Pran Kishore Deb, Raghu Prasad Mailavaram, Balakumar Chandrasekaran, Sonja Kachler, Karl-Norbert Klotz, Abdul Muttaleb Yousef Jaber
7-Amino-2-aryl/hetero-aryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and adenosine receptor binding studies. Chemical biology & drug design 94 (2) (2019)
Stephanie Federico, Enrico Margiotta, Silvia Paoletta, Sonja Kachler, Karl-Norbert Klotz, Kenneth A Jacobson, Giorgia Pastorin, Stefano Moro, Giampiero Spalluto
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example. MedChemComm 10 (7) (2019)
Riccardo Petrelli, Mirko Scortichini, Carmela Belardo, Serena Boccella, Livio Luongo, Fabio Capone, Sonja Kachler, Patrizia Vita, Fabio Del Bello, Sabatino Maione, Antonio Lavecchia, Karl-Norbert Klotz, Loredana Cappellacci
Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists. Journal of medicinal chemistry 61 (1) (2018)
Marthe Koussémou, Kristina Lorenz, Karl-Norbert Klotz
The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1. PloS one 13 (8) (2018)
Panagiotis Lagarias, Eleni Vrontaki, George Lamprinidis, Dimitrios Stamatis, Marino Convertino, Gabriella Ortore, Thomas Mavromoustakos, Karl-Norbert Klotz, Antonios D Kolocouris
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode. Journal of chemical information and modeling 58 (4) (2018)
Pran Kishore Deb, Raghuprasad Mailavaram, Balakumar Chandrasekaran, Venkata Rao Kaki, Rajwinder Kaur, Sonja Kachler, Karl-Norbert Klotz, Raghuram Rao Akkinepally
Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives. Chemical biology & drug design 91 (4) (2017)